{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:54:49Z","timestamp":1776128089487,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"George and Emily McMichael Harrison Fund, Penn Presbyterian Harrison Fund of the University of Pennsylvania Hospital Obstetrics and Gynecology Department"},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","award":["124268-IRG-78-002-35-IRG"],"award-info":[{"award-number":["124268-IRG-78-002-35-IRG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1136\/ijgc-2019-000566","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T04:15:10Z","timestamp":1562991310000},"page":"1177-1181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Low rate of intraperitoneal port placement in ovarian cancer patients, a population-based assessment"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2227-5913","authenticated-orcid":false,"given":"Lindsey","family":"Buckingham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen M","family":"Brensinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawar","family":"Latif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L","family":"Giuntoli II","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-000566_bb0010","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2019-000566_bb0015","article-title":"Cancer Facts & Figures","volume":"2015","author":"Society AC","year":"2015"},{"key":"10.1136\/ijgc-2019-000566_bb0020","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2019-000566_bb0025","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMe048292","article-title":"The if and when of surgical debulking for ovarian carcinoma","volume":"351","author":"Thigpen","year":"2004","journal-title":"N Engl J Med Overseas Ed"},{"key":"10.1136\/ijgc-2019-000566_bb0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","article-title":"Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure","volume":"89","author":"Dedrick","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2019-000566_bb0035","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2019-000566_bb0040","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"JCO"},{"key":"10.1136\/ijgc-2019-000566_bb0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2019-000566_bb0050","author":"Intraperitoneal Chemotherapy for Ovarian Cancer","year":"2006","journal-title":"Nih cancer therapy evaluation program"},{"key":"10.1136\/ijgc-2019-000566_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2014.00043","article-title":"Diffusion of Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer in Community Settings 2003\u00e2\u20ac\u201c2008: The Effect of the NCI Clinical Recommendation","volume":"4","author":"Bowles","year":"2014","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ygyno.2014.06.011","article-title":"Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer","volume":"134","author":"Fairfield","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0065","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1200\/JCO.2015.61.4776","article-title":"Use and effectiveness of intraperitoneal chemotherapy for treatment of ovarian cancer","volume":"33","author":"Wright","year":"2015","journal-title":"JCO"},{"key":"10.1136\/ijgc-2019-000566_bb0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/IGC.0000000000000330","article-title":"Feasibility and safety of a modified outpatient regimen with intravenous\/intraperitoneal chemotherapy for optimally debulked stage III ovarian cancer","volume":"25","author":"Bruixola","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000566_bb0075","author":"Surgeons ACo","year":"2013","journal-title":"User guide for the 2012 ACS NSQIP participant use data file"},{"key":"10.1136\/ijgc-2019-000566_bb0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/SLA.0b013e3181b4148f","article-title":"Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals","volume":"250","author":"Hall","year":"2009","journal-title":"Ann Surg"},{"key":"10.1136\/ijgc-2019-000566_bb0085","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jamcollsurg.2007.03.028","article-title":"The patient safety in surgery study: background, study design, and patient populations","volume":"204","author":"Khuri","year":"2007","journal-title":"J Am Coll Surg"},{"issue":"Suppl 1","key":"10.1136\/ijgc-2019-000566_bb0090","first-page":"S161","article-title":"Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2019-000566_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2015.11.022","article-title":"Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: an external validation study of three models using computed tomography","volume":"140","author":"Rutten","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0105","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-000566_bb0110","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/IGC.0b013e31826a3559","article-title":"Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a retrospective French multicentric study","volume":"22","author":"Luyckx","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000566_bb0115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ijgc-00009577-200603000-00005","article-title":"Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures","volume":"16","author":"Tentes","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000566_bb0120","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/IGC.0b013e318265d358","article-title":"Comparison of morbidity and survival between primary and interval cytoreductive surgery in patients after modified posterior pelvic exenteration for advanced ovarian cancer","volume":"22","author":"Revaux","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000566_bb0125","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/IGC.0b013e31823de6ae","article-title":"Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA\u2013IV: analysis of the OVCAD data","volume":"22","author":"Polterauer","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-000566_bb0130","unstructured":"Oncology SoG . Quality indicators. Available: https:\/\/www.sgo.org\/quality-outcomes-and-research\/quality-indicators\/ [Accessed 2\/13\/19 2019]."},{"key":"10.1136\/ijgc-2019-000566_bb0135","first-page":"208","article-title":"A phase III clinical trial of bevacizumab with IV versus IP chemotherapy in ovarian, fallopian tube, and primary peritoneal carcinoma a GOG\/NRG trial (GOG 252)","volume":"141","author":"Walker","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0140","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1200\/JCO.18.01568","article-title":"Randomized trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: an NRG Oncology\/Gynecologic Oncology Group study","volume":"37","author":"Walker","year":"2019","journal-title":"JCO"},{"key":"10.1136\/ijgc-2019-000566_bb0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ygyno.2011.07.031","article-title":"It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by interventional radiologists for percutaneous placement of intraperitoneal chemotherapy catheters","volume":"123","author":"Henretta","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jmig.2011.06.005","article-title":"Laparoscopic intraperitoneal port placement for optimally cytoreduced advanced ovarian cancer","volume":"18","author":"Janco","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1136\/ijgc-2019-000566_bb0155","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ygyno.2007.10.004","article-title":"Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates","volume":"108","author":"Landrum","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ygyno.2012.03.027","article-title":"Progression-free and overall survival of a modified outpatient regimen of primary intravenous\/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer","volume":"125","author":"Barlin","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1758834010361333","article-title":"Review: practical considerations in ovarian cancer chemotherapy","volume":"2","author":"Cristea","year":"2010","journal-title":"Ther Adv Med Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2005.11.013","article-title":"Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group study","volume":"100","author":"Walker","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2009.04.001","article-title":"Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer","volume":"114","author":"Naumann","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000566_bb0180","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2009.05.036","article-title":"Outcomes associated with different intraperitoneal chemotherapy delivery systems in advanced ovarian carcinoma: a single institution's experience","volume":"114","author":"Ivy","year":"2009","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24002585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24002585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-000566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:24:46Z","timestamp":1753233886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24002585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1048891X24002585"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-000566","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low rate of intraperitoneal port placement in ovarian cancer patients, a population-based assessment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-000566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}